Tag: Iv antibiotics

The overall incidence of osteomyelitis, or bone infection, is estimated to be 21.8 cases per 100,000 person-years [1.2.2]. The answer to **which antibiotic is used for bone infection** depends on the specific bacteria causing the infection and individual patient factors [1.10.1].

According to the Centers for Disease Control and Prevention (CDC), *Pseudomonas aeruginosa* caused an estimated 32,600 infections among hospitalized patients in 2017 alone, with many strains exhibiting high resistance. Consequently, determining the appropriate course of IV antibiotics for *Pseudomonas* is a complex medical decision that varies significantly based on the infection's location and severity, as well as the patient's individual health factors.

Claforan (cefotaxime) is a potent, third-generation cephalosporin antibiotic used to treat a wide variety of serious and life-threatening bacterial infections. An estimated 12% of hospital patients receive antibiotics, and Claforan IV is often reserved for complex cases where a powerful, broad-spectrum drug is necessary to combat resistant bacteria and prevent complications.

Kenzolin is a brand name for the combination antibiotic medication piperacillin and tazobactam, which is used to treat a wide array of serious bacterial infections throughout the body. Over 2,600 patients worldwide were treated with this drug combination during initial clinical trials, highlighting its widespread use for complex infections. This powerful medication is specifically designed to combat certain bacteria, including those that have developed resistance to some other antibiotics.